GlassScriptPhysician profile
Tarun Sabharwal
NPI 1164873311
$1,265.13
in general payments reported to CMS, 2019-2025
8 companies · $549 in 2025
The $549 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $616 · 2020: $99.99 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $549.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Guerbet LLC | $549.37 | 2025 | |
| Janssen Pharmaceuticals, INC | $221.48 | 2019 | |
| Janssen Biotech, INC. | $125.00 | 2019 | |
| Pfizer INC. | $121.00 | 2019 | |
| Astellas Pharma US INC | $109.32 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.99 | 2020 | |
| Theratechnologies INC. | $20.71 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $18.26 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarun Sabharwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.